Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Capecitabine Market

Capecitabine Market Share

Report ID: GMI6855
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Capecitabine Market Share

Major players operating in the capecitabine is as mentioned below:

Sun Pharmaceutical Industries Ltd
Shilpa Medicare limited
Atom Pharma
Global Calcium
LGM Pharma
Dr. Reddy’s Laboratories Ltd
Cipla Ltd
Zeon Pharma
Avanscure Lifesciences Pvt Ltd
Hepartex

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Capecitabine industry size was USD 408.2 million in 2022 and may reach USD 652.9 million by 2032 driven by rising importance in offering significant clinical effectiveness in treating different cancer

The breast cancer indication segment may record USD 265.8 million by end of 2032 driven by the growing prescription for the treatment of metastatic breast cancer due to its proven efficacy.

North America market size may reach USD 252.5 million by end of 2032 due to the presence of well-established network of domestic and international pharmaceutical manufacturers

Some of the major capecitabine providers are Global Calcium, Sun Pharmaceutical Industries Ltd, Shilpa Medicare limited, Atom Pharma, Avanscure Lifesciences Pvt Ltd, Cipla Ltd, LGM Pharma, Dr. Reddy’s Laboratories Ltd, and Zeon Pharma